1. The activities of some membrane-bound enzymes such as adenylate cyclase, Na++K+-stimulated adenosine triphosphatase (Na+ +K+-ATPase), a'+-stimulated ATPase and MgZ +-stimulated ATPase were examined in heart sarcolemmal fractions from control and cardiomyopathic hamsters at different stages of heart failure.
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ma1 abnormalities (Dhalla, McNamara & Anand, 1976) , and indeed sarcolemmal changes are believed to play a crucial role in the development of heart failure (Dhalla, Tomlinson, Singh, Lee, McNamara, Harrow & Yates, 1976 ).
Earlier we demonstrated dramatic changes in sarcolemmal Na + + K + -ATPase, Ca2 + -ATPase and MgZ +-ATPase activities without alteration in basal adenylate cyclase activity at terminal stages of heart failure in genetically cardiomyopathic (UM-X7.1) hamsters (Singh, Dhalla, McNamara, Bajusz & Jasmin, 1975) . This strain of myopathic hamsters shows 100% incidence of heart failure and has been regarded as a suitable model for monitoring biochemical changes at different stages of the disease (Jasmin & Bajusz, 1973; Borowski, Harrow, Pritchard & Dhalla, 1974; Jasmin & Solymoss, 1975; Harrow, Singh, Jasmin & Dhalla, 1975) ; The present investigation examined the activities of different enzymes in heart sarcolemma in these hamsters at early, moderate and severe stages of heart failure. In addition to comparisons of membranes from the control and experimental animals, some experiments have been carried out to decide whether differences between these preparations are due to cytoplasmic contamination or to artifacts from the isolation procedure.
Materials and methods
Healthy inbred Syrian hamsters (control animals) and cardiomyopathic hamsters (UM-X7.1) of various ages were used. This UM-X7.1 line of cardiomyopathic hamsters has been established by cross-breeding homozygous diseased animals of the BIO 14.6 strain with unrelated healthy hamsters and by recovering the mutant gene in the F2 generation (Jasmin & Bajusz, 1973) . The average life-span of these new cardiomyopathic hamsters is about 200 days, which is almost one-third of the normal life-expectancy of this species. They showed more severe cardiac lesions with 100% incidence of congestive heart failure compared with the BIO 14.6 strain of hamsters. Histological studies (Jasmin & Bajusz, 1973) at 120-200 days of age showed various degrees of myocardial focal necrosis and interstitial oedema similar to that reported for the BIO 14.6 strain (Bajusz & Lossnitzer, 1968; Bajusz, Baker, Nixon & Hornburger, 1969) . The hamsters were divided into three groups with respect to their age, heart/body weight ratio, pulmonary oedema, liver congestion and generalized oedema. On the basis of these pathological and clinical observations we believe that cardiomyopathic hamsters of ages 120-150 days, 155-175 days and 180-200 days were at early, moderate and severe stages of heart failure respectively. Healthy hamsters of the same age groups were used for comparison. All animals were decapitated, and the hearts quickly removed and placed in ice-cold Tris-HC1 buffer, pH 7.4. Three to four hearts were pooled and the ventricles used to prepare the sarcolemmal fraction by the hypotonic shock-LiBr treatment procedure . The ventricles were homogenized in a medium containing Tris-HC1 (10 mmol/l), pH 7-4, and EDTA (1 mmol/l). The lo00 g sediment was suspended in Tris-HC1 buffer, pH 7.4, stirred for 30 min and centrifuged at loo0 g for 10 min. This procedure was repeated by using Tris-HC1 buffer at pH 8.0 and then at pH 7.4. The residue thus obtained was extracted with LiBr (400 mmol/l) in Tris-HC1 (10 mmol/l), pH 7.4, for 45 f i n , and after washing the loo0 g sediment was extracted with KCl (0.6 mol/l) for 30 min and centrifuged at loo0 g. This sediment was throughly washed and suspended in Tris-HC1 (1 mmolll), pH 7.4. This membrane fraction consisted of vesicles of different shapes and s u e s and showed negligible activities of cytochrome c oxidase, glucose 6-phosphatase and acid phosphatase similar to those reported for the dog heart sarcolemmal preparation (McNamara, Sulakhe, Singh & Dhalla, 1974) . In one experiment, the control and cardiomyopathic sarcolemmal preparations were further purified by employing a discontinuous sucrose gradient consisting of 70, 60 and 50% sucrose in Tris-HCl (10 mmol/l), pH 7-4, but no appreciable increase in its enzyme activities or loss of proteins was seen.
Both mitochondria1 and microsomal fractions were isolated by differential centrifugation (Sulakhe & Dhalla, 1971 b) . The protein concentration of the cellular fractions was determined by the method of Lowry, Rosebrough, Farr & Randall (1951) . The Na + + K +-ATPase activity was determined by incubating the sarcolemmal fraction in a medium containing Tris-HC1 (50 mmolll), pH 7.4, MgCL (4 mmolll), NaCl (100 mmolll), KCl (10 mmol/l) and ATP (4 mmol/l) in the absence or presence of ouabain (2 mmol/l) at 37°C for 10 min. The reaction was terminated by the addition of 1 ml of cold 12% tricbloroacetic acid and the Pi in the clear supernatant was determined by the method of Taussky Sarcolemma in failing heart 235 & Shorr (1953) . The difference between the results in the absence and presence of ouabain gave the Na++K+-ATPase activity. The activity of Cal+-ATPase or MgZ+-ATPase was determined by incubating the membranes at 37°C in a medium containing Tris-HC1 (50 mmol/l), pH 7-4, and ATP (4 mmolll) in the absence and presence of Ca2+ or Mg'+ (each 4 mmol/l). The non-specific phosphatase activity was determined by incubating these membranes at 37°C in a medium containing and EGTA (1-2 mmol/l). The adenylate cyclase was determined by the method of Drummond & Duncan (1970) . For this purpose the membranes were incubated at 37°C in a medium containing Tris-HC1 (50 mmolll), pH 8.5, caffeine (8 mmol/l), KCl (5 mmol/l), phosphoenolpyruvate (20 mmolll), MgCl, (15 mmol/l), pyruvate kinase (130 pg/ml) and [l4c]ATP (0-4 mmol/l). The reaction was started by the addition of ATP and stopped by boiling the tubes for 3 min under conditions preventing evaporation, with prior addition of cold cyclic AMP (2 mmolll). The clear supernatant (100 pl) was subjected to descending chromatography and the radioactivity in the cyclic AMP spot was estimated in a Packard liquid-scintillation counter. The results were corrected by subtracting the non-enzymic formation of cyclic AMP due to denatured enzyme preparation. All these procedures for the determination of enzyme activities are described in detail elsewhere (McNamara er ul., 1974) and any changes in the experimental conditions are indicated in the text. The membranes from the control and cardiomyopathic animals were prepared Tris-HC1 (50 mmolll), PH 7.4, ATP (4 mmol/l) simultaneously and 50-60 pg of proteins of these fractions were employed in each reaction within 1 h of isolation. For determining calcium binding, membrane preparations (0.2-0.3 mg of proteinlml) were incubated at 25°C in a medium containing TrisHC1 (50 mmol/l), pH 7.0, and 45CaC11 (0.1 mmol/l) for 5 min and the reaction was terminated by the Millipore filtration technique (Sulakhe & Dhalla, 1971b) . Theresults were analysed statistically by Student's t-test.
Results
The liver and heart weights, heart/body weight ratio and the heart sarcolemmal yield for the control and cardiomyopathic animals of different age groups were determined and the results are given in Table 1 . Signilicant (P<O.O5) increases in heart weight and heartlbody weight ratio were seen at moderate and severe stages of heart failure in cardiomyopathic hamsters whereas the liver weight was increased (P<O.O5) only at the severe stages. On the other hand, the sarcolemmal yield from the cardiomyopathic hearts was markedly less at early, moderate and severe stages of failure in comparison with hearts of control hamsters. It should be noted that the sarcolemmal yield reported here is less than theoretical since much is lost during the isolation and purification procedures.
In one series of experiments the adenylate cyclase activities of the control heart and cardiomyopathic sarcolemma were determined in the absence (basal) or presence of its well-known activators such as Liver wt. Heart wt. lo3 x Heart yield (mg of (9) (9) wt./body wt. proteinlg of heart)
Control ( NaF and noradrenaline. The results for wdiomyopathic hearts at different stages of failure are shown in Table 2 . The basal, NaF-stimulated and noradrenaline-stimulated adenylate cyclase activities of the cardiomyopathic sarcolemma at early stages of failure were not different (P > 0.05) from the control values. However, the NaF and noradrenalinestimulated adenylate cyclase activities of the cardiomyopathic sarcolemma at moderate and severe stages of failure were significantly (P < 0.05) lower than the activity of the control without any appreciable changes in the basal adenylate cyclase activity. The adenylate cyclase activities of the heart homogenate and washed cell particles in the presence of NaF or another activator, isoproterenol, were lower (P < 0.05) in cardiomyopathic animals at severe stages of heart failure ( Table 3) . On the other hand, the basal adenylate cyclase activities of the cardiomyopathic heart homogenate and washed cell particle preparations were not significantly different from the control values (P z 0.05). Fig. 1 also shows that the basal adenylate cyclase activity of the wdiomyopathic sarcolemma is not significantly different (P =-0.05) from the control preparation when determinations were made at different pH values of the incubation medium. On the other hand, the cardiomyopathic sarcolemmal adenylate cyclase activities in the presence of different concentrations of NaF (Fig. 2) and isoproterenol (Fig. 3) were significantly lower (P < 0.05) than the control values. It should be noted that the basal adenylate cyclase activities were increased only about fourfold in the sarcolemmal preparations compared with hamster wholeheart homogenates, whereas six-to eight-fold increases have been observed for dog, rat and rabbit hearts by the method used in this study. This difference is due to the higher enzyme activity of the hamster heart homogenate since the enzyme activities of sarcolemmal preparations were comparable in different species (unpublished observations).
In another series of experiments, the ATPhydrolysing activities of the control heart and cardiomyopathic sarcolemma were determined and the results are shown in Table 4 . It was found that the Na + + K +-ATPase activity was decreased whereas the non-specific phosphatase activity was increased significantly (P < 0.05) in the cardiomyopathic sarcolemma at early, moderate and severe stages of failure. On the other hand, Mg2+-ATPase activity decreased significantly (P < 0.05)
only at the severe stages of failure but Ca2 +-ATPase activity of the cardiomyopathic sarcolemma decreased both at moderate and severe stages of failure.
Depressed Na + + K + -ATPase, Mg2 + -ATPase and Cat +-AWase activities of cardiomyopathic sarcolemma at severe stages were apparent at different substrate concentrations employed in the assay media ( complex in the heart sarcolemma. However, it is apparent from the results described here that the sarcolemmal Na+ +K+-ATPase is more sensitive to myopathic changes than Caz+-ATPase or Mg2+-ATPase in this model of heart failure. The activities of several sarcolemmal enzymes such as adenylate cyclase, Na+ +K+-ATPase, Mg2+-ATPase and Caz +-ATPase from cardiomyopathic hamster hearts were no different when the sarcolemma1 preparations were isolated from cardiomyopathic heart homogenates containing other added mitochondrial or microsomal fractions ( Table 6 ).
In one experiment the control ventricles were homogenized in the absence and presence of 10% by weight of connective tissues (dissected from the peripheral tissues) and the sarcolemmal preparations thus obtained were found to have identical enzyme activities. Further, the sarcolemmal Ca2 +-ATPase, Mg2+-APTase and Na+ +K+-ATPase activities of the control hearts homogenized in 5000 g supernatant from control hearts were not different (P > 0.05) from those homogenized in the supernatant from cardiomyopathic hearts (Table 7) . It should be noted that mitochondria1 and microsomal fractions, unlike the sarcolemmal fraction, showed neither an ouabain-sensitive N a + + K+-ATPase activity nor a significant (P>O.O5) depression in Ca2+-ATPase and Mg2 +-ATPase activities (Table 8 ).
The control heart and cardiomyopathic (severe stages) sarcolemma were found to bind 43 + 4 and 21 + 3 nmol of Ca2 + 5 min-l mg-' of proteininthe absence of Mg-ATP. Unlike mitochondrial and microsomal fractions, the calcium binding by the sarcolemmal fraction employed in this study is markedly inhibited by the presence of Mg-ATP .
The N a + +K+-ATPase was also prepared from the control and cardiomyopathic (severe stages of failure) hearts by the NaI treatment method . The specific activities of the Na+ +K+-ATPase for the control and cardiomyopathic preparations were found to be 26.3 f 1.7 and 17.2 f 1.5 pmol of PI h -mg-of protein.
No difference in the inhibitory responses of control and cardiomyopathic Na + + K + -ATPase preparations to ouabain was seen; 50% inhibition of the enzyme activity was apparent with ouabain at about 1 pmol/l.
Discussion
In this study we have shown changes in the Na + + K +-ATPase, Ca2 +-ATPase, Mg2 +-ATPase, NaF-stimulated adenylate cyclase, catecholaminestimulated adenylate cyclase and non-specific phosphatase activities in heart sarcolemma from cardiomyopathic hamsters. These alterations in the enzyme activities do not appear to be due to contamination of the cardiomyopathic sarcolemmal fraction since its basal adenylate cyclase activity was no different from the control, and the nonspecific phosphatase activity was increased whereas other ATPase activities were decreased. Furthermore it was possible to detect a similar pattern of changes in the adenylate cyclase activities in cardiomyopathic tissue homogenates and washed cell particle preparations. Isolation of the heart sarcolemmal fraction from homogenates in the presence of exogenously added mitochondria1 and microsomal fractions as well as those from connective tissues had no effect. Since the Ca2+-ATPase and Mg2+-ATPase activities of the cardiomyopathic mitochondrial and microsomal fractions were not increased and no N a + +K+-ATPase activity was demonstrable, it is unlikely that the observed changes in the sarcolemmal ATPase activities are due to redistribution of these enzymes. Nor can these changes be attributed to the release of some membrane-rupturing enzymes during homogenization of the cardiomyopathic hearts, since the ATPase activities of sarcolemma obtained by homogenizing the control heart in 5000 g supernatants from the control and cardiomyopathic hearts were similar. It should be noted that the enzyme activities of the control hamster heart sarcolemma are comparable with those reported in other species by other methods (Stam et al., 1970 ; Sulakhe & Dhalla, 1971a; Kidwai et al., 1971; Tada et al., 1972) . Although mitochondrial and microsomal marker enzyme activities were minimal in the preparations employed in this study, we do not claim that the sarcolemmal fractions are pure. Furthermore, dramatic changes in the ATPase activities of skeletal muscle sarcolemma prepared by different methods in these myopathic hamsters have also been observed (Dhalla, Singh, Lee, Anand, Bernatsky & Jasmin, 1975) . Indeed, until it is clearly shown that the method of preparation does yield a true sarcolemmal fraction and that the enzymatic components evaluated do correspond to cell membrane localizations in vivo, we suggest that our data should be interpreted with some caution.
We have shown that the N a + +K+-ATPase activity of heart sarcolemma of the cardiomyopathic hamster was decreased at early, moderate and severe stages of failure, whereas the Ca2 +-ATPase activity was decreased at the moderate and severe stages and the Mg2 +-ATPase activity was decreased only at the severe stages of failure. We have also observed a decrease in the specific activity of the cardiomyopathic N a + +K+-ATPase enzyme preparation obtained by the NaI treatment. This is in contrast to the results reported with N a + + K + -ATPase enzyme preparation obtained from the BIO 14.6 strain of rnyopathic hamsters . Increased sarcolemmal N a + + K + -ATPase activity has also been observed in the hearts of myotonic rats after induction of cardiomegaly by diazacholesterol (Fiehn, Seiler, Kuhn & Bartels, 1975) . However, a decrease in Na + + K + -ATPase activity has been reported in failing hearts due to aortic constriction, hypoxia, lack of substrate and myocardial ischaemia (Yazaki & Fujii, 1972 ; Balasubramanian, McNamara, Singh & Dhalla, 1973 ; Dhalla, Singh, Fedelesova, Balasubramanian & McNamara, 1974;  Schwartz, Wood, Allen, Bornet, Entman, Goldstein, Sordahl & Suzuki, 1973) . Although Mead, Peterson & Welty (1971) failed to detect any change in the Na+ +K+-ATPase activity in dog hearts failing owing to pulmonary artery stenosis, the enzyme activity of the control preparations employed by these investigators is far below the accepted range of values.
These conflicting reports may be due to differences in the experimental models of heart failure. At any rate, the observed changes in sarcolemmal ATPase activities may partly account for dramatic alterations in the electrolyte content of hearts of the UM-X7.1 strain of cardiomyopathic animals (Borowski et al., 1974) .
Our data reveal that the heart sarcolemmal adenylate cyclase activities in the presence of NaF or catecholamines are depressed in cardiomyopathic hamsters at moderate and severe stages of failure without any changes in the basal adenylate cyclase activity. No appreciable change in adenylate cyclase activity of the heart washed cell particles were seen in myopathic hamsters (BIO 14.6) with a moderate degree of heart failure although responses of the enzyme to noradrenaline and NaF were markedly altered in late stages of failure (Sulakhe 8c Dhalla, 1972) . Conflicting reports have appeared on changes in the adenylate cyclase activities of the heart washed cell particles in the absence or presence of its activators for different models of heart failure (Sulakhe & Dhalla, 1972; Sobel, Henry, Robison, Bloor & Ross, 1969; Gertler, Saluste & Spencer, 1970; Gold, Prindle, Levey & Epstein, 1970; Dhalla, Sulakhe, Khandelwal & Olson, 1972; McNamara et al., 1973) ; however, we think that such changes depend on the degree and type of heart failure. Although the observed decrease in adenylate cyclase activity in the presence of catecholamine may suggest a loss of adrenergic support to the failing myocardium, our results show that this system is not affected in the early stages of heart failure.
These comparative studies of different enzyme activities may indicate a sarcolemmal defect in the failing hearts of cardiomyopathic hamsters. In particular, a depressed Na + + K +-AVase activity of heart sarcolemma at the early stages of heart failure suggest a close association of this membrane defect with development of this failure. It should be noted that inhibition of Na+ +K+-ATPase may be associated with an increased calcium influx (Schwartz et ul., 1972) , which could explain the intracellular calcium overload in these failing hearts (Jasmin & Solymoss, 1975; Borowski et al., 1974) . However, our results show a reduction in calcium-binding abilities of heart mitochondria and sarcoplasmic reticular membranes at early stages of heart failure in these cardiomyopathic hamsters (unpublished observations). Thus it becomes conceivable that generalized membrane changes during the development of heart failure OCCUT owing to some alteration in membrane phospholipid and protein content and this may play an important role in the pathogenesis of heart failure. However, any causative relationship of the observed sarcolemma1 changes to heart failure in cardiomyopathic hamsters remains to be investigated.
